Please login to the form below

Not currently logged in
Email:
Password:

Breo Ellipta

This page shows the latest Breo Ellipta news and features for those working in and with pharma, biotech and healthcare.

Sovaldi pushes Gilead to the top of US pharma list

Sovaldi pushes Gilead to the top of US pharma list

The London-based firm has also failed to increase market share for its next-gen versions of Advair - namely Breo, Ellipta and Anoro Ellipta - which had combined sales last year of

Latest news

  • China weighs heavy on GSK figures in Q3 China weighs heavy on GSK figures in Q3

    There were also launches for melanoma drugs Tafinlar (dabrafenib) and Mekinist (trametinib), Tivicay (dolutegravir) for HIV via GSK's ViiV joint venture with Pfizer and Shionogi, and new COPD therapy Breo ... Ellipta (fluticasone furoate and vilanterol).

  • GSK wins US approval for Seretide successor Breo Ellipta GSK wins US approval for Seretide successor Breo Ellipta

    GSK wins US approval for Seretide successor Breo Ellipta. FDA gives green light to COPD combination. ... The partners plan to launch Breo Ellipta in the US during the third quarter of this year.

  • GSK buoyed by FDA panel backing for Advair successor GSK buoyed by FDA panel backing for Advair successor

    Breo, delivered once-daily using a new Ellipta inhaler, is seen as a critical drug for GSK as it tries to defend its asthma and COPD franchise dominated by twice-daily ... Breo Ellipta (which will be sold as Relvar in Europe) is being positioned by GSK

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics